News from orbusneich A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

May 20, 2021, 05:00 ET TricValve® Transcatheter Bicaval Valves System Receives CE Mark

May 20, 2021, 05:00 ET TricValve® Transcatheter Bicaval Valves System Receives CE Mark

OrbusNeich® Medical Company Ltd. and P&F Products & Features®, under the joint partnership OrbusNeich P&F, today announced that the TricValve®...

Nov 09, 2020, 06:00 ET OrbusNeich® Medical and P+F Products & Features® announce new partnership

OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative...

Nov 09, 2020, 06:00 ET OrbusNeich® Medical and P+F Products & Features® announce new partnership

Sep 25, 2019, 11:22 ET OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent

Sep 25, 2019, 06:00 ET OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent

OrbusNeich Medical K.K. of Tokyo Japan has announced that the Japan Ministry of Health, Labour, and Welfare (MHLW) has granted Shonin market approval ...

Nov 01, 2017, 14:10 ET Late-Breaking REDUCE Trial Data Demonstrate Non-inferiority of 3 vs 12 Months Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Treated With the COMBO[TM] Stent

One-year results from the REDUCE trial reported at TCT 2017 OrbusNeich has reported results from the REDUCE trial today in the Late-Breaking Clinical ...

Nov 01, 2017, 14:10 ET Late-Breaking REDUCE Trial Data Demonstrate Non-inferiority of 3 vs 12 Months Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Treated With OrbusNeich's COMBO[TM] Stent

OrbusNeich has reported results from the REDUCE trial today in the Late-Breaking Clinical Trial session at the 29th annual Transcatheter...

Oct 30, 2017, 14:15 ET OrbusNeich's COMBO™ Dual Therapy Stent Demonstrates Non-inferiority vs the Market Leading XIENCE™ Everolimus Eluting Stent

New results from the HARMONEE Japan/US Registration Trial, reported by OrbusNeich today in the First Report Investigations session at the 29th annual ...

Oct 23, 2017, 06:56 ET OrbusNeich Announces Schedule of Events at TCT 2017

Program to include late-breaking presentation of REDUCE clinical trial Data on more than 5,000 patients to be presented OrbusNeich, a global company...

Jun 06, 2017, 05:30 ET OrbusNeich Announces FDA Clearance, Launch of Coronary Dilatation Catheters

Jun 06, 2017, 05:30 ET OrbusNeich gibt FDA-Zulassung und Markteinführung von Kathetern für die Koronardilatation bekannt

Jun 06, 2017, 05:30 ET OrbusNeich annonce l'autorisation de la FDA pour le lancement de ses cathéters de dilatation coronaire

Jun 06, 2017, 05:30 ET OrbusNeich Announces FDA Clearance, Launch of Coronary Dilatation Catheters

Announcement marks company's official entry into the US market OrbusNeich, a global company specializing in the provision of life-changing vascular...

Jun 06, 2017, 05:30 ET OrbusNeich anuncia la aprobación de la FDA y el lanzamiento de lo catéteres de dilatación coronaria

Jan 11, 2017, 05:00 ET OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Balloon

Jan 11, 2017, 04:00 ET OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Balloon

Launch of Scoreflex™ NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global company...

Jan 11, 2017, 04:00 ET OrbusNeich erweitert sein Portfolio um einen neuartigen Non-Compliant Koronar-Scoring-Ballonkatheter

Jan 11, 2017, 04:00 ET OrbusNeich élargit sa gamme avec un ballon de scoring coronaire de nouvelle génération

Jan 11, 2017, 04:00 ET OrbusNeich amplía su cartera con un balón de scoring coronario de nueva generación

Nov 21, 2016, 05:30 ET OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing

Nov 21, 2016, 05:30 ET OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing

COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced...

Nov 21, 2016, 05:30 ET OrbusNeich presenta el nuevo COMBO Plus Dual Therapy Stent

May 24, 2016, 05:29 ET OrbusNeich expande su cartera para tratar la enfermedad arterial periférica

May 24, 2016, 05:20 ET OrbusNeich erweitert sein Portfolio um die Behandlung der peripheren arteriellen Verschlusskrankheit